Genetic and Environmental Contributions to Human Longevity
lnsan ömrünün en kompleks fenotipler gibi, hem çevresel (yaşam tarzı, nerede yaşadığın gibi) hem de genetik faktörlerin kompleks etkileşimlerinin yansıması olduğunu düşündürür. Bu faktörler muhtemelen yaşlanmanın temel mekanizmalarını ve büyük ölçüde yaşla ilişkili hastalıkları etkiler. Hastalıklara direnç gösteren varyantların eksikliği kadar hastalıklara yatkınlığı arttıran varyantların varlığında da iyi yaşam tercihi ve tamamlayıcı çevre varlığı ileri yaşlara ulaşmada hayati önem taşıyacaktır. Uzun yaşamın bilimsel mekanizması hakkındaki bilgilerimiz hala yetersiz olmasına rağmen, çevrenin ve genlerin potansiyel katkıları da dahil yaşlanmanın biyolojik temellerini anlamak bireyin yaşam tarzı tercihlerini şekillendirmesi ve ömrünün uzaması için etkili tedavi hedefleri geliştirmek için anahtardır. Bu derleme, insan uzun ömrünün genetik ve çevresel temellerinin entegre edildiği farklı stratejilere farklı bir bakış açısı sağlayacaktır.
Genetik ve Çevrenin Insan Omrüne Katkıları
lnsan ömrünün en kompleks fenotipler gibi, hem çevresel (yaşam tarzı, nerede yaşadığın gibi) hem de genetik faktörlerin kompleks etkileşimlerinin yansıması olduğunu düşündürür. Bu faktörler muhtemelen yaşlanmanın temel mekanizmalarını ve büyük ölçüde yaşla ilişkili hastalıkları etkiler. Hastalıklara direnç gösteren varyantların eksikliği kadar hastalıklara yatkınlığı arttıran varyantların varlığında da iyi yaşam tercihi ve tamamlayıcı çevre varlığı ileri yaşlara ulaşmada hayati önem taşıyacaktır. Uzun yaşamın bilimsel mekanizması hakkındaki bilgilerimiz hala yetersiz olmasına rağmen, çevrenin ve genlerin potansiyel katkıları da dahil yaşlanmanın biyolojik temellerini anlamak bireyin yaşam tarzı tercihlerini şekillendirmesi ve ömrünün uzaması için etkili tedavi hedefleri geliştirmek için anahtardır. Bu derleme, insan uzun ömrünün genetik ve çevresel temellerinin entegre edildiği farklı stratejilere farklı bir bakış açısı sağlayacaktır.
___
- 1. Hjelmborg J, Iachine I, Skytthe A, Vaupel JW, McGue M, Koskenvuo M et al. Genetic influence on human lifespan and longevity. Hum Genet. 2006;119:31221.
- 2. Tan Q, De Benedictis G, Yashin AI, Bathum L, Christiansen L, Dahlgaard J et al. Assessing genetic association with human survival at multiallelic loci. Biogerontology. 2004;5:8997.
- 3. Terry DF, Wilcox M, McCormick MA, Lawler E, Perls TT. Cardiovascular advantages among the offspring of centenarians. J Gerontol A Biol Sci Med Sci. 2003; 58:M42531
- 4. Terry DF, Wilcox MA, McCormick MA, Pennington JY, Schoenhofen EA, Andersen SL et al. Lower allcause, cardiovascular, and cancer mortality in centenarians' offspring. J Am Geriatr Soc. 2004;52:20746.
- 5. Mariani F, PérezBarahona A, Raffin N. Life expectancy and the environment. J Econ Dyn Control. 2010;34:798815
- 6. Vagero D. Health inequalities across the globe demand new global policies. Scand J Public Healt. 2007;35:1135.
- 7. Breyer F, Lorenz N, Niebel T. Health care expenditures and longevity: is there a Eubie Blake effect? Eur J Health Econ. 2005;16:95112.
- 8. Finch CE, Tanzi RE. Genetics of ageing. Science. 1997;278: 40711.
- 9. Herskind AM, McGue M, Holm NV, Sørensen TI, Harvald B, Vaupel JW. The heritability of human longevity: a populationbased study of 2872 Danish twin pairs born 18701900. Hum Genet. 1996;97:31923.
- 10. Ljungquist B, Berg S, Lanke J, McClearn GE, Pedersen NL. The effect of genetic factors for longevity: a comparison of identical and fraternal twins in the Swedish Twin Registry. J Gerontol A Biol Sci Med Sci. 1998;53:M4416.
- 11. Puca AA, Daly MJ, Brewster SJ, Matise TC, Barrett J, SheaDrinkwater M et al. A genomewide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc Natl Acad Sci USA. 2001;98:105058.
- 12. Beekman M, Blanche H, Perola M, Hervonen A, Bezrukov V, Sikora E et al. Genomewide linkage analysis for human longevity: genetics of healthy aging study. Aging Cell. 2013;12:18493.
- 13. Bush WS, Moore JH. Chapter 11:Genomewide association studies. PLoS Comput Biol. 2012;8:e1002822.
- 14. Segura V, Vilhjálmsson BJ, Platt A, Korte A, Seren Ü, Long Q et al. An efficient multilocus mixedmodel approach for genomewide association studies in structured populations. Nat Genet. 2012;44:82530.
- 15. Amos CI. Successful design and conduct of genomewide association studies. Hum Mol Genet. 2007;16:2205.
- 16. The International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299320.
- 17. The International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007;449:85161.
- 18. Manolio TA, Collins FS. The HapMap and genomewide association studies in diagnosis and therapy. Annu Rev Med. 2009;60:44356.
- 19. Spencer CCA, Su Z, Donnelly P, Marchini J. Designing genomewide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet. 2009;5:e1000477.
- 20. Montesanto A, Dato S, Bellizzi D, Rose G, Passarino G. Epidemiological, genetic and epigenetic aspects of the research on healthy ageing and longevity. Immun Ageing. 2012;9:6..
- 21. Awofala AA. Genetic approaches to alcohol addiction: gene expression studies and recent candidates from Drosophila. Invert Neurosci. 2011;11:17.
- 22. Awofala AA, Davies JA, Jones S. Functional roles for redox genes in ethanol sensitivity in Drosophila. Funct Integr Genomics. 2012;12:30515.
- 23. Browner WS, Kahn AJ, Ziv E, Reiner AP, Oshima J, Cawthon RM et al. The genetics of human longevity. Am J Med. 2004;117:851.
- 24. Kenyon CJ. The genetics of ageing. Nature. 2010;464:50412.
- 25. Fontana L, Partridge L, Longo VD. Extending healthy life spanfrom yeast to humans. Science. 2010;328:3216.
- 26. de la Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res. 2012;9:3566.
- 27. Corbo RM, Pinto A, Scacchi R. Genderspecific association between FSHR and PPARG common variants and human longevity. Rejuvenation Res. 2013;16:217.
- 28. Anselmi CV, Malovini A, Roncarati R, Novelli V, Villa F, Condorelli G et al. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res. 2009;12:95104.
- 29. Fraga MF, Esteller M. Epigenetics and ageing: the targets and the marks. Trends Genet. 2007;23:4138.
- 30. van Vliet J, Oates NA. Epigenetic mechanisms in the context of complex diseases.Cell Mol Life Sci. 2007;64:15318.
- 31. Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science. 1999;286:4816.
- 32. Gonzalo S. Epigenetic alterations in ageing. J Appl Physiol. 2010;109:58697.
- 33. Awofala AA. Molecular and genetic determinants of alcohol dependence. J Addict Dis. 2013;32:293309.
- 34. Fraga MF. Genetic and epigenetic regulation of ageing. Curr Opin Immunol. 2009;21:44653.
- 35. Yan MSC Matouk CC, Marsden PA. Epigenetics of the vascular endothelium. J Appl Physiol. 2010;109:91626.
- 36. Tan Q, Christiansen L, Bathum L, Zhao JH, Yashin AI, Vaupel JW et al. Estimating haplotype relative risks on human survival in populationbased association studies. Hum Hered. 2005;59:8897.
- 37. Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H et al. Decline in genomic DNA methylation through ageing in a cohort of elderly subjects. Mech Ageing Dev. 2009;130:2349.
- 38. Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med. 2010;16:23846.
- 39. Gravina S, Vijg J. Epigenetic factors in ageing and longevity. Pflüg Arch Eur J Phy. 2010;459:247 58
- 40. Gentilini D, Mari D, Castaldi D, Remondini D, Ogliari G, Bucci L et al. Role of epigenetics in human ageing and longevity: genomewide DNA methylation profile in centenarians and centenarians’ offspring. Age. 2012;113.
- 41. Mathers JC. Nutritional modulation of ageing: genomic and epigenetic approaches. Mech Ageing Dev. 2006;127:5849.
- 42. Sedivy JM, Banumathy G, Adams PD. Aging by epigenetics–a consequence of chromatin damage? Exp Cell Res. 2008;314:190917.
- 43. Niculescu MD, Lupu DS. Nutritional influence on epigenetics and effects on longevity. Curr Opin Clin Nutr Metab Care. 2011;14:3540.
- 44. Barker DJ, Osmond C. Infant mortality childhood nutrition, and ischaemic heart disease in England and Wales. Lancet. 1986;1:107781.
- 45. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and earlylife conditions on adult health and disease. N Engl J Med. 2008;359:6173.
- 46. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin S L, RaoMelacini P et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a casecontrol study.Lancet. 2010;376:11223.
- 47. Yusuf S, Hawken S, Ôunpuu S, Bautista L, Franzosi MG, Commerford P et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a casecontrol study. Lancet. 2005;366:16409.
- 48. Spindler SR. Caloric restriction: from soup to nuts. Ageing Res Rev. 2010;9:32453.
- 49. Masoro EJ. Overview of caloric restriction and ageing. Mech Ageing Dev. 2005;126:91322.
- 50. Roth GS, Lane MA, Ingram DK, Mattison JA, Elahi D, Tobin JD et al. Biomarkers of caloric restriction may predict longevity in humans. Science. 2002;297:811.
- 51. Soare A, Cangemi R, Omodei D, Holloszy JO, Fontana L. Longterm calorie restriction, but not endurance exercise, lowers core body temperature in humans. Aging (Albany NY). 2011;3:3749.
- 52. Sinclair DA. Toward a unified theory of caloric restriction and longevity regulation. Mech Ageing Dev. 2005;126:9871002.
- 53. U.S. Department of Health and Human Services. Promoting active lifestyles among older adults. A report: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Centrer for Disease Control and Prevention. Accessed 10 July 2015, .
- 54. Beekman M, Nederstigt C, Suchiman HE, Kremer D, van der Breggen R, Lakenberg N et al. Genomewide association study (GWAS)identified disease risk alleles do not compromise human longevity. Proc Natl Acad Sci USA. 2010;107:180469.
- 55. Hunter DJ. Geneenvironment interactions in human diseases. Nat Rev Genet. 2005;6:28798.
- 56. Narasimhan SD, Yen K, Tissenbaum HA. Converging pathways in lifespan regulation. Curr Biol. 2009;19:R657R666.
- 57. Stanfel MN, Shamieh LS, Kaeberlein M, Kennedy BK. The TOR pathway comes of age. Biochim Biophys Acta. 2009;1790:106774.
- 58. Pollak MN, Schernhammer ES, Hankinson SE. Insulinlike growth factors and neoplasia. Nat Rev Cancer. 2004;4:50518.
- 59. Cohen E, Paulsson JF, Blinder P, BurstynCohen T, Du D, Estepa G et al. Reduced IGF1 signaling delays ageassociated proteotoxicity in mice. Cell. 2009;139:115769.
- 60. Smith DL, Jr, Elam CF, Jr, Mattison JA, Lane MA, Roth GS, Ingram DK et al. Metformin supplementation and life span in Fischer344 rats. J Gerontol A Biol Sci Med Sci. 2010;65:46874.
- 61. Bonkowski MS, Rocha JS, Masternak MM, Al Regaiey KA, Bartke A. Targeted disruption of growth hormone receptor interferes with the beneficial actions of calorie restriction. Proc Natl Acad Sci USA. 2006;103:79015.
- 62. GuevaraAguirre J, Balasubramanian P, GuevaraAguirre M, Wei M, Madia F, Cheng CW et al. Growth hormone receptor deficiency is associated with a major reduction in proaging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3:70ra13.
- 63. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for lifespan extension by calorie restriction in Saccharomyces cerevisiae. Science. 2008;289:21268.
- 64. Guerrero RF, GarcíaParrilla MC, Puertas B, CantosVillar E. Wine, resveratrol and health: a review. Nat Prod Commun. 2009;4:63558.
- 65. Baur JA. Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev. 2010; 31:261 9.
- 66. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 2010;285:8340 51.
- 67. Rea IM, Mc Dowell I, McMaster D, Smye M, Stout R, Evans A et al. Apolipoprotein E alleles in nonagenarian subjects in the Belfast Elderly Longitudinal Freeliving Ageing Study (BELFAST). Mech Ageing Dev. 2001;122:136772.
- 68. Hagberg JM, Wilund KR, Ferrell RE. Apo E gene and geneenvironment effects on plasma lipoproteinlipid levels. Physiol Genomics. 2000;4:1018.
- 69. Schachter F, Fauredelanef L, Guenot F, Rouger H, Froguel P, LesueurGinot, L et al. Genetic associations with human longevity at the Apoe and Ace loci. Nat Genet. 1994;6:2932.
- 70. Evans WE, McLeod HL. Pharmacogenomics: drug disposition, drug targets, and side effects. N Engl J Med. 2003;348:53849
- 71. Jack CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9:11928.
- 72. Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust WJ. Alzheimer’s disease neurodegenerative biomarkers are associated with decreased cognitive function but not betaamyloid in cognitively normal older individuals. J Neurosci. 2013;33:555363.
- 73. Drenos F, Kirkwood TBL. Selection on Alleles Affecting Human Longevity and LateLife Disease: The Example of Apolipoprotein E. PLoS ONE. 2010;5:e10022.
- 74. Feng J, Xiang L, Wan G, Qi K, Sun L, Huang Z et al. Is APOE epsilon3 a favourable factor for the longevity: an association study in Chinese population. J Genet. 2011;90:3437.
- 75. Blanche H, Cabanne L, Sahbatou M, Thomas GA. Study of French centenarians: are ACE and APOE associated with longevity? Comptes Rendus De L Academie Des Sciences Serie IIISciences De La VieLife Sciences. 2001;324:12935.
- 76. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the epsilon 2 allele of apolipoprotein E: The Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci. 2001;56:M75M78.
- 77. Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang RA. C. elegans mutant that lives twice as long as wild type. Nature. 1993;366:4614.
- 78. Murphy CT, McCarroll A, Bargmann I, Fraser A, Kamath R, Ahringer J et al. Genes that act downstream of DAF16 to influence the life span of Caenorhabditis elegans. Nature. 2003;424:27783.
- 79. Willcox BJ, Timothy AD, Qimei He, Randi C, John SG et al. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci USA. 2008;105:1398792.
- 80. Imae M, Fu Z, Yoshida A, Noguchi T, Kato H. Nutritional and hormonal factors control the gene expression of FoxOs, the mammalian homologues of DAF16. J Mol Endocrinol. 2003;30:25362.
- 81. Clare MJ, Luckinbill LS. The effects of geneenvironment interaction on the expression of longevity. Heredity. 1985;55:1926.
- 82. Keith CT, Borisy AA, Stockwell BR. Multicomponent therapeutics for networked systems. Nat Rev Drug Discov. 2005;4:71–8.
- 83. Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4:68290.
- 84. Csermely P, Agoston V, Pongor S. The efficiency of multitarget drugs: the network approach might help drug design. Trends Pharmacol Sci. 2005;26:17882.
- 85. Hong SE, Heo HS, Kim DH, Kim MS, Kim CH, Lee J et al. Revealing systemlevel correlations between aging and calorie restriction using a mouse transcriptome. Age (Dordr). 2010;32:1530.
- 86. Goldberg AD, Allis CD, Bernstein E.Epigenetics: a landscape takes shape. Cell. 2007;128:6358.
- 87. Spindler SR. Use of microarray biomarkers to identify longevity therapeutics. Aging Cell. 2006;5:3950.
- 88. Simkó GI, Gyurkó D, Veres DV, Nánási T, Csermely P. Network strategies to understand the aging process and help agerelated drug design. Genome Med. 2009;1:90.